Home | Publications | Treatments | Skin care place holder
place holder place holder

Skin care


Medicated Skin Care in Belgium


Publication Date   January 2008
Publisher   Euromonitor International
Product Type   Report
Pages   39
ISBN Number   not applicable
Product Code   EUR827
Ask a question about this product?

Price £450.00

approximately: $793 | €558

Summary


Euromonitor International's Medicated Skin Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - India

OTC Healthcare in India : Market Insight

EXECUTIVE SUMMARY
Economic growth spurs sales Eye care boosted by growing computer usage Fragmented shares led by multinationals Distribution remains fairly limited Steady growth expected for forecast period KEY TRENDS AND DEVELOPMENTS
Introduction of Schedule K amendments promise good growth Retailers play an important role in dispensing drugs Switch to herbal products from standard Urbanisation and busier lifestyles boost sales Economic growth makes healthcare more affordable TERRITORY KEY TRENDS AND DEVELOPMENTS
East and Northeast India North India South India West India RURAL VS URBAN KEY TRENDS AND DEVELOPMENTS
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 Sales of OTC Healthcare by Region: Value 2001-2006
Table 5 Sales of OTC Healthcare by Region: % Value Growth 2001-2006
Table 6 Sales of OTC Healthcare by Rural-Urban % Value Analysis 2006
Table 7 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 8 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
Table 13 Forecast Sales of OTC Healthcare by Region: Value 2006-2011
Table 14 Forecast Sales of OTC Healthcare by Region: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins and dietary supplements registration and classification Generics Consumer expenditure on health goods and medical services
Table 15 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - India

Amrutanjan Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 2 Amrutanjan Ltd: Key Facts
Summary 3 Amrutanjan Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 4 Amrutanjan Ltd: Production Statistics 2005-2006
COMPETITIVE POSITIONING
Summary 5 Amrutanjan Ltd: Competitive Position 2006
Amway India Enterprises - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 6 Amway India Enterprises: Key Facts
Summary 7 Amway India Enterprises: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 8 Amway India Enterprises: Competitive Position 2006
Dabur India Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 9 Dabur India Ltd: Key Facts
Summary 10 Dabur India Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 11 Dabur India Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 12 Dabur India Ltd: Competitive Position 2006
Emami Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 13 Emami Ltd: Key Facts
Summary 14 Emami Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 15 Emami Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 16 Emami Ltd: Competitive Position 2006
GlaxoSmithKline Pharmaceuticals (India) Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 17 GlaxoSmithKline Pharmaceuticals Ltd: Key Facts
Summary 18 GlaxoSmithKline Pharmaceuticals Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 19 GlaxoSmithKline Pharmaceuticals Ltd: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 20 GlaxoSmithKline Pharmaceuticals Ltd: Competitive Position 2006
Nicholas Piramal India Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 21 Nicholas Piramal India Ltd: Key Facts
Summary 22 Nicholas Piramal India Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 23 Nicholas Piramal India Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 24 Nicholas Piramal India Ltd: Competitive Position 2006
Paras Pharmaceuticals Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 25 Paras Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 26 Paras Pharmaceuticals Ltd: Competitive Position 2006
Pfizer Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 27 Pfizer Ltd: Key Facts
Summary 28 Pfizer Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 29 Pfizer Ltd: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 30 Pfizer Ltd: Competitive Position 2006
Ranbaxy Laboratories Ltd - OTC Healthcare - India
STRATEGIC DIRECTION KEY FACTS
Summary 31 Ranbaxy Laboratories Ltd: Key Facts
Summary 32 Ranbaxy Laboratories Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 33 Ranbaxy Laboratories Ltd: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 34 Ranbaxy Laboratories Ltd: Competitive Position 2006

NRT Smoking cessation aids in India

HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 16 Number of Smokers by Gender 2001-2006